Open Access<p>MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP)</p>
Author(s) -
Niuniu Li,
ChunChia Cheng,
Tieyan Wang
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s245254
Subject(s) - vimentin , carcinogenesis , cancer research , cd44 , cell growth , apoptosis , western blot , microbiology and biotechnology , cell , immunohistochemistry , biology , chemistry , cancer , medicine , gene , immunology , biochemistry , genetics
Cervical cancer (CC) is a highly prevalent cancer and one of the main causes of death among women worldwide. The miR-181 family has turned out to be associated with tumorigenesis in a variety of tumors by regulating the expression of tumor-related genes. However, the mechanisms and biological function of miR-181c-5p in cervical squamous cell carcinoma (SCC) have not been well elucidated.